177 related articles for article (PubMed ID: 34267237)
1. Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia.
Al-Mohammed HI; Sulieman A; Mayhoub FH; Salah H; Lagarde C; Alkhorayef M; Aldhebaib A; Kappas C; Bradley DA
Sci Rep; 2021 Jul; 11(1):14557. PubMed ID: 34267237
[TBL] [Abstract][Full Text] [Related]
2. Occupational and ambient radiation exposures from Lu-177 DOTATATE during targeted therapy.
Sulieman A; Mayhoub FH; Salah H; Al-Mohammed HI; Alkhorayef M; Moftah B; Al Rowaily M; Bradley DA
Appl Radiat Isot; 2020 Oct; 164():109240. PubMed ID: 32819499
[TBL] [Abstract][Full Text] [Related]
3. Recommended restrictions after 131I therapy: measured doses in family members.
Mathieu I; Caussin J; Smeesters P; Wambersie A; Beckers C
Health Phys; 1999 Feb; 76(2):129-36. PubMed ID: 9929123
[TBL] [Abstract][Full Text] [Related]
4. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.
Barrington SF; Kettle AG; O'Doherty MJ; Wells CP; Somer EJ; Coakley AJ
Eur J Nucl Med; 1996 Feb; 23(2):123-30. PubMed ID: 8925845
[TBL] [Abstract][Full Text] [Related]
6. An engagement factor for caregiver radiation dose assessment with radioiodine treatment.
Lee HK; Hong SJ; Jeong KH; Jung JW; Kim SM; Kang YH; Han MS
Radiat Prot Dosimetry; 2015 Mar; 163(4):499-508. PubMed ID: 25028695
[TBL] [Abstract][Full Text] [Related]
7. Hand exposure of nuclear medicine workers during administration of radioiodine.
Wrzesien M; Olszewski J
Radiat Prot Dosimetry; 2012 Aug; 151(1):147-52. PubMed ID: 22147924
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
9. Staff and ambient radiation dose resulting from therapeutic nuclear medicine procedures.
Alkhorayef M; Sulieman A; Mohamed-Ahmed M; Al-Mohammed HI; Alkhomashi N; Sam AK; Bradley DA
Appl Radiat Isot; 2018 Nov; 141():270-274. PubMed ID: 30145016
[TBL] [Abstract][Full Text] [Related]
10. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
[TBL] [Abstract][Full Text] [Related]
11. [Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities].
Sapienza MT; Willegaignon J; Ono CR; Watanabe T; Guimarães MI; Gutterres RF; Maréchal MH; Buchpiguel CA
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):318-25. PubMed ID: 19578592
[TBL] [Abstract][Full Text] [Related]
12. Measurement of radiation exposure in relatives of thyroid cancer patients treated with (131)I.
Ramírez-Garzón YT; Ávila O; Medina LA; Gamboa-deBuen I; Rodríguez-Laguna A; Buenfil AE; Ruíz-Trejo C; Estrada E; Brandan ME
Health Phys; 2014 Nov; 107(5):410-6. PubMed ID: 25271931
[TBL] [Abstract][Full Text] [Related]
13. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
Al-Shakhrah IA
Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
[TBL] [Abstract][Full Text] [Related]
14. Unexpected dose to the daughter of a patient treated with iodine-131 for hyperthyroidism.
Molyvda-Athanasopoulou E; Karaveli M; Chatzigiannaki A; Gotzamani-Psarrakou A
Hell J Nucl Med; 2007; 10(3):175-6. PubMed ID: 18084660
[TBL] [Abstract][Full Text] [Related]
15. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
16. Measurements and prediction of the ambient dose rate from patient receiving radioiodine administration after thyroid ablation.
Kim CB; Jung JW; Jeong KH; Ahn BC; Lee HH; Lee J
Radiat Prot Dosimetry; 2012 Aug; 151(1):158-61. PubMed ID: 22171099
[TBL] [Abstract][Full Text] [Related]
17. Management of the helpless patient after radioiodine ablation therapy - are we being too strict?
Williams CE; Woodward AF
Nucl Med Commun; 2005 Oct; 26(10):925-8. PubMed ID: 16160653
[TBL] [Abstract][Full Text] [Related]
18. Fetal dose estimates and the ICRP abdominal dose limit for occupational exposure of pregnant staff to technetium-99m and iodine-131 patients.
Mountford PJ; Steele HR
Eur J Nucl Med; 1995 Oct; 22(10):1173-9. PubMed ID: 8542902
[TBL] [Abstract][Full Text] [Related]
19. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
